Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants

JAMA Oncol. 2024 Nov 1;10(11):1588-1590. doi: 10.1001/jamaoncol.2024.3683.
No abstract available

Plain language summary

This cohort study examines the risk of radiation-associated sarcoma in patients with breast cancer harboring germline TP53 variants.